If you have an illness or condition that requires a medication or other product containing a substance that is on the Prohibited List, a Therapeutic Use Exemption (TUE) may be granted that permits you to use the medication/product without committing an Anti-Doping Rule Violation, providing that all such use is in accordance with the conditions of the TUE.
If you are unsure whether you require a TUE or would like to check whether a supplement or medication contains a prohibited substance; please download and complete a 'Product Information Request Form'. The completed from should then be sent to IDTM using one of the following methods:
· By email to: tennis@idtm.se
· By fax to: +46 8 555 10 995
· By registered post/courier to: IDTM, Stockholmsvägen 18, 181 33 Lidingö, Sweden
To apply for a TUE:
- Download a TUE Application Form (avalibale on this page and at www.idtm.se)
- Ask your physician to complete the form in UPPER CASE and in English, and preferably typed. If the form is incomplete or illegible, it will be returned.
- Submit the completed form to IDTM, with all necessary supporting medical evidence,(please download the 'Supporting Medical Information' document at the bottom of this page for more information).
- If you do not receive notification that your TUE application has been received within 72 hours, you should contact IDTM again, as it may be that your contact information is illegible or incorrect and that they have been unable to contact you.
- An application for a new TUE (or renewal of an existing TUE) should be submitted at least 30 days in advance of the first date on which use of the substance is required.
- Please note that failure to provide the required information may result in the application being denied, and/or returned, whilst if the information provided is inconclusive, you may be requested to supply additional information, which will thereby delay the processing of an application.
- You are advised not to use any prohibited substance without a valid TUE.
Regulations for use of glucocorticosteroids
A TUE is required for glucocorticosteroids administered by the following routes:
• Oral
• Intravenous
• Intramuscular
• Rectal
Topical (i.e. surface) application of glucocorticosteroids is not prohibited and does not require a TUE. These methods of administration are:
• Auricular
• Buccal
• Dermatological (including iontophoresis/phonophoresis)
• Opthalmic
• Nasal
• Perianal
Regulations for use of beta-2-agonists
All beta-2-agonists are prohibited except inhaled salbutamol (maximum 1600 micrograms over 24 hours), inhaled formoterol (maximum delivered dose 54 micrograms over 24 hours) and salmeterol when taken by inhalation in accordance with the manufacturers' recommended therapeutic regime.
Intravenous infusions
Intravenous infusions are prohibited unless legitimately received in the course of hospital admissions or clinical investigations.
Retroactive TUEs
Applications for retroactive TUEs are limited to medical emergencies and ‘exceptional circumstances’. Exceptional circumstances are those in which “there was insufficient time or opportunity for an applicant to submit, or a TUE Committee to consider, an application prior to Doping Control.” For further information on retroactive TUEs, please download the pdf document below.